Absci entered its new drug into Phase I trials in half the time and for many millions of dollars less than it would have cost without AI.

Artificial Intelligence (AI) is now used throughout clinical trials, from recruitment to analysis – but are regulators ...

Generative AI can support decisions about a clinical trial’s target patient population by enhancing subgroup discovery, refining trial eligibility criteria, and helping remove patients who are ...

While Quantum computing has been reported to be five years away for many years now, companies are preparing for it by setting ...

One of the most notable trends highlighted in the study is the shift toward lightweight AI models optimized for execution in ...

Praneeth Reddy Sudalagunta, PhD, discusses a novel generative artificial intelligence pipeline developed to help with the understanding and treatment of multiple myeloma.

Having humans participate in a study can be time-consuming and expensive for researchers stretching limited budgets on strict ...

A great example is AI. There is no limit to how you could use generative AI in clinical research, but a lot of it is not necessarily going to meet the needs of our customers. Our core customers at ...

The demand for AI in clinical trials is experiencing strong growth, primarily fueled by the rising global prevalence of chronic illnesses like diabet ...

Scaling productivity for health care providers,” highlights how generative artificial intelligence (AI) can offer a critical ...